Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 171 (Search time: 0.002 seconds).
previous
1
2
3
4
...
18
next
Item hits:
Preview
Issue Date
Title
Author(s)
2016
ABCB1 overexpression predicts outcome of CML patients undergoing first-line imatinib treatment
Eadie, L.
;
Hughes, T.
;
White, D.
;
New Directions in Leukaemia Research 2016 Meeting (NDLR) (16 Mar 2016 - 19 Mar 2016 : Noosa, QLD)
1997
Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia.
Lewis, I.
;
Haylock, D.
;
Moore, S.
;
To, L.
;
Hughes, T.
1998
Stem cell factor as a single agent induces marked proliferation of the philadelphia chromosome positive fraction of CML CD34+ cell
Moore, S.
;
Haylock, D.
;
Levesque, J.P.
;
McDiarmid, L.
;
Samels, L.
;
To, L.
;
Simmons, P.
;
Hughes, T.
2008
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?
Hughes, T.
2014
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint
Branford, S.
;
Ross, D.
;
Yeung, D.
;
Braley, J.
;
Hughes, T.
;
56th ASH Annual Meeting (6 Dec 2014 - 9 Dec 2014 : San Francisco, California)
2004
Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation
Szer, J.
;
Durrant, S.
;
Schwarer, A.
;
Bradstock, K.
;
Gibson, J.
;
Arthur, C.
;
To, L.
;
Hughes, T.
;
Raunow, H.
2004
Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia
Mollee, P.
;
Arthur, C.
;
Hughes, T.
;
Januszewicz, H.
;
Grigg, A.
;
Bradstock, K.
;
Wolf, M.
;
Gibson, J.
;
Schwarer, A.
;
Spencer, A.
;
Browett, P.
;
Hawkins, T.
;
Seldon, M.
;
Herrmann, R.
;
Watson, A.
;
Seymour, J.
;
Martin, N.
;
Shina, S.
;
Low, C.
;
Wright, S.
;
et al.
2013
STAT5 is a critical component of the time-dependent sensitivity of CML cells to TKI treatment in a BCR-ABL-dependent, but JAK2-independent manner
Schafranek, L.
;
Nievergall, E.
;
Powell, J.
;
Hiwase, D.
;
White, D.
;
Hughes, T.
;
Leclercq, T.
2000
A new rare t(9;11)(p22;p15) in acute leukaemia
Nicola, M.
;
Suttle, J.
;
Beerworth, J.
;
Dobrovic, A.
;
Hughes, T.
;
Moore, S.
2010
Selective escalation of imatinib therapy and early switching to nilotinib in de novo chronic phase CML patients: interim results from the TIDELL-II trial
Yeung, D.
;
Osborn, M.
;
White, D.
;
Branford, S.
;
Haswell, L.
;
Slader, C.
;
Issa, S.
;
Hiwase, D.
;
Hertzberg, M.
;
Schwarer, A.
;
Filshie, R.
;
Arthur, C.
;
Kwan, Y.
;
Forsyth, C.
;
Ross, D.
;
Mills, A.
;
Grigg, A.
;
Hughes, T.
;
Annual Meeting of the American Society of Hematology (52nd : 2010 : Orlando, Fl.)
Discover
Author
11
Hiwase, D.
11
Seymour, J.
10
et al.
10
Parker, W.
10
Schwarer, A.
10
Zannettino, A.
9
Martinelli, G.
8
Druker, B.
8
Kok, C.
8
Rudzki, Z.
.
< previous
next >
Subject
90
Humans
65
Pyrimidines
64
Leukemia, Myelogenous, Chronic, B...
55
Piperazines
54
Benzamides
52
Imatinib Mesylate
42
Antineoplastic Agents
40
Fusion Proteins, bcr-abl
38
Protein Kinase Inhibitors
31
Male
.
next >
Date issued
1
2020 - 2022
97
2010 - 2019
64
2000 - 2009
9
1995 - 1999